Life Sciences Litigation Insights: April 2022
CRA’s Life Sciences Litigation team provides periodic summaries of notable developments in litigation. In this issue, we share notable cases from 2021 and...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA’s experts provide economic and damages testimony and analysis in support of IP-related litigation in all venues, including US District Court, State Court, ITC, PTAB and in International Arbitration proceedings. Courts increasingly require rigorous economic analysis in the determination of damages awards. Our industry knowledge and expertise in economics, finance, accounting, and business strategy make us uniquely qualified to understand and convey the value and impact of proprietary rights in the marketplace. We prepare and defend well-supported positions based on comprehensive analysis, and deliver clear and compelling testimony.
CRA’s Life Sciences Litigation team provides periodic summaries of notable developments in litigation. In this issue, we share notable cases from 2021 and...
In this Law360 article, Fei Deng, Hong Qiao, and Yi Cheng examine the trend of Chinese courts toward awarding larger non-statutory damage awards in IP cases....
Anna Soubbotina presents during the session to discuss intangible property valuation in the context of transfer pricing. For more information on this event,...
Fei Deng is a commentator during the session titled “High Tech Patent Licensing: Automobile/SEP licensing, Patent Pool licensing.” For more information on this...